Filing search / Mirum Pharmaceuticals, Inc. / "Materials" / Page 3

8-K

erici21ksudd

11 Jan 22

Mirum Pharmaceuticals Provides Business Update and Highlights Key 2022 Corporate Milestones

9:00am

DEFA14A

yep6zckyf

14 Apr 21

Additional proxy soliciting materials

4:10pm

D

hfn30bi6

30 Dec 20

$10M in equity, sold $10M, 3 investors

5:18pm

424B5

wf7og ltgm80

15 Dec 20

Prospectus supplement for primary offering

4:57pm

424B5

7y8iv91i

14 Dec 20

Prospectus supplement for primary offering

7:13am

8-K

EX-99.2

w0mlix8ahv e2dq9

10 Dec 20

Revenue Interest Purchase Agreement

9:11am

8-K

EX-99.1

3o5ng 08inojvl2lic

10 Dec 20

Revenue Interest Purchase Agreement

9:11am

S-3/A

7cm8cn6lqnhc

10 Aug 20

Shelf registration (amended)

4:11pm